Sunbelt Securities’s XBiotech XBIT Stock Holding History

Sunbelt Securities’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$5	–	2973
2025 Q3	$5	Buy	+2	New	+$6	﹤0.01%	2693

Other funds holding XBIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sunbelt Securities's XBIT Position: Q4 2025 in Review

Sunbelt Securities sold out of XBiotech (XBIT) in Q4 2025, closing a stake of 2 shares — an estimated $5 sold.

Sunbelt Securities first reported a position in XBIT in Q3 2025 and held it in 1 quarter. The position peaked at $5 in Q3 2025. 41 funds tracked by Wall St. Rank hold XBIT as of Q4 2025.

Sunbelt Securities reported no remaining XBiotech position as of Q4 2025 after selling out during the quarter.
Sunbelt Securities sold 2 XBiotech shares in Q4 2025, an estimated $5.
Sunbelt Securities first reported a position in XBiotech in Q3 2025 and held it in 1 quarter.
Sunbelt Securities's XBiotech position peaked at $5 in Q3 2025.
41 funds tracked by Wall St. Rank held XBiotech as of Q4 2025.

Based on Sunbelt Securities's 13F filing for Q4 2025, filed 20 Feb 2026.